AI Insight
Researchers developed GITIII-scale, an artificial intelligence foundation model that analyzes the tumor microenvironment by learning how cancer cells interact with their neighboring cells through chemical signals. The model was trained on matched single-cell RNA sequencing and spatial transcriptomics data from multiple cancer types and uses interpretable transformer architectures to identify specific ligand-receptor signaling pathways that influence cell behavior. In validation tests, GITIII-scale outperformed existing spatial transcriptomics models at predicting cell state changes in unseen cancer types and successfully identified potential drug targets in breast cancer related to blood vessel overgrowth and tumor development.
Why it matters
This interpretable AI model could accelerate cancer drug discovery by pinpointing specific cell-cell communication pathways that drive tumor progression, offering more targeted therapeutic intervention points. The model's ability to work across cancer types and provide mechanistic explanations makes it particularly valuable for translating computational predictions into testable biological hypotheses and potential treatments.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Abstract: In the tumor microenvironment, cell’s state is influenced by cell-cell interactions (CCIs) with neighboring cells in its niches. Identifying dysregulated CCIs that are associated with pathogenic process pinpoints targets for drug discovery. Imaging-based spatial transcriptomics and single-cell RNA sequencing provide, respectively, single-cell spatial information and transcriptome-wide measurements needed to study CCIs, but neither modality provides both. Existing spatial transcriptomics foundation models also cannot effectively learn from spatially resolved single-cell data with full-transcriptome coverage, explicitly infer the CCI mechanisms driving cell state-niche associations, or interpretable enough to support direct biological interpretations. Here, we present GITIII-scale, a hierarchical, interpretable pan-cancer spatial transcriptomics foundation model for TME representation learning that investigates cell state-niche associations and their underlying ligand-receptor (LR) signaling pathways. GITIII-scale uses transformers to model interactions between pairs of cells at defined spatial distances, an interpretable single-layer graph transformer without a feed-forward network to decompose how each gene in a receiver cell is influenced by each neighboring sender cell, and a graph transformer to generate cellular-neighborhood embeddings. Trained on our assembled pan-cancer database of specimen-matched scRNA-seq and imaging-based spatial transcriptomics datasets, GITIII-scale generated TME embeddings that recovered niche-associated state changes more accurately than existing spatial transcriptomics foundation models in cancer types unseen during training. A case study of an unseen breast cancer dataset further demonstrated the model’s interpretability by identifying potentially drug-targetable LR pathways associated with endothelial overgrowth and tumorigenesis.